RET/PTC activation in human thyroid carcinomas

This publication has 9 references indexed in Scilit:

• Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
  1994
• Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
  Human Molecular Genetics, 1993
• Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
  Nature, 1993
• Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.
  Molecular and Cellular Biology, 1993
• Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
  Journal of Clinical Investigation, 1992
• Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.
  Proceedings of the National Academy of Sciences, 1992
• THE RET PROTOONCOGENE IS CONSISTENTLY EXPRESSED IN HUMAN PHEOCHROMOCYTOMAS AND THYROID MEDULLARY CARCINOMAS
  1990
• PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas
  Published by Elsevier ,1990
• A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases
  Nature, 1987